Related Experiment Video
Updated: May 31, 2026
09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Acute renal dysfunction in patients with alcoholic hepatitis.
Robin Arora1, Shweta Kathuria, Nishant Jalandhara
1Robin Arora, Nishant Jalandhara, Division of Nephrology, Department of Internal Medicine, Tulane University, New Orleans, LA 70118, United States.
World Journal of Hepatology
|July 7, 2011
Summary
Acute renal dysfunction is a common and deadly complication of alcoholic hepatitis. While treatments like Pentoxifylline and molecular adsorbent recirculation systems show promise, larger studies are needed to confirm their effectiveness in improving patient outcomes.
Area of Science:
- Hepatology
- Nephrology
- Critical Care Medicine
Background:
- Alcoholic hepatitis (AH) frequently causes acute kidney injury (AKI).
- AKI significantly elevates mortality risk in AH patients.
- Current management strategies offer limited improvement in outcomes for AH with AKI.
Purpose of the Study:
- To review the current landscape of treatments for alcoholic hepatitis with acute kidney dysfunction.
- To highlight emerging therapeutic modalities and their potential impact.
Main Methods:
- Review of existing literature on treatments for alcoholic hepatitis and acute kidney injury.
- Analysis of data from small studies investigating Pentoxifylline and molecular adsorbent recirculation systems.
Main Results:
- Small studies suggest potential benefits of Pentoxifylline and molecular adsorbent recirculation systems.
- These novel treatments have shown encouraging preliminary data in specific patient cohorts.
Conclusions:
- Acute kidney dysfunction remains a critical challenge in alcoholic hepatitis management.
- Larger, well-designed clinical trials are essential to validate the efficacy of Pentoxifylline and molecular adsorbent recirculation systems for AH treatment.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:22Acute Kidney Injury I: Introduction
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
01:29Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...